Complications of Ethanol-amine Oleate Intralesional Sclerotherapy

Completed

• Conditions: Venous Malformation

• Registration Number: NCT04930952
• Lead Sponsor: Suez Canal University

Brief Summary

The aim of this study is to clarify complications of Ethanolamine Oleate intralesional injections of maxillofacial venous formations in pediatric patients

Detailed Description

Maxillofacial Venous malformations cause many functional and esthetic complications in children, intralesional sclerotherapy is the best choice of treatment; and Ethanol-amine Oleate has been the most commonly used sclerosing agent.

The aim of this study is to clarify complications of Ethanolamine Oleate intralesional injections of maxillofacial venous formations

Study Timeline

• Study Start: 2019-02-28
• Primary Completion: 2021-02-28
• Study Completion: 2021-03-03
• Status Verified: 2021-06
• Study First Submitted: 2021-06-11
• Study First Submitted QC: 2021-06-11
• Last Update Submitted: 2021-06-11
• Study First Posted: 2021-06-18
• Last Update Posted: 2021-06-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

maxillofacial venous malformation

Exclusion Criteria

1. Patients with lung, liver, or kidney diseases
2. Patients with Klippel-Trenaunay syndrome
3. Patients mental or physical disabilities

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical Response	12 months	Complete Response - Marked Improvement - Moderate Improvement - No Response

Trial Locations

Locations (1)

Suez Canal University; 🇪🇬 Ismailia, Egypt